Also has the whole body to use the antibacterials to have the appraisal! This billion yuan product has reached 8

Original: Wei Xi On February 14, Xinhua Pharmaceutical announced that the company had recently received the approval document for supplementary drug application of Cefalexin Capsules (0.25g and 0.125g) approved and issued by the State Food and drug administration, which passed the consistency evaluation of quality and efficacy of generic drugs According to the data of minenet, the terminal sales of Cefalexin in China's public medical institutions reached 265 million yuan in 2018 Up to now, the products have been evaluated as capsules and 8 enterprises have been evaluated Table 1: basic information of drugs Figure 1: Sales of Cefalexin in public medical institutions in China (unit: 10000 yuan) Source: the terminal competition pattern of Chinese public medical institutions in the Internet Cefalexin is the first generation of oral cephalosporin antibiotics It was first synthesized by Eli Lilly company in the United States It is mainly used to treat mild infection caused by sensitive bacteria According to the data of minenet, in 2018, the sales of Cefalexin reached 265 million yuan in China's urban public hospitals, county-level public hospitals, urban community centers and township health centers (referred to as China's public medical institutions), of which 62.01% was capsule Figure 2: over evaluation of cephalexin related products up to now